UK markets closed

UnitedHealth Group Incorporated (0R0O.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
518.360.00 (0.00%)
At close: 07:09PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-0.31%
S&P500 52-week change 318.96%
52-week high 3557.99
52-week low 3446.52
50-day moving average 3497.20
200-day moving average 3491.56

Share statistics

Avg vol (3-month) 359.32k
Avg vol (10-day) 3214.89k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8925.38M
% held by insiders 10.23%
% held by institutions 189.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 37.74
Trailing annual dividend yield 31.49%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 3.66%
Operating margin (ttm)7.97%

Management effectiveness

Return on assets (ttm)7.07%
Return on equity (ttm)15.58%

Income statement

Revenue (ttm)385.44B
Revenue per share (ttm)418.27
Quarterly revenue growth (yoy)6.40%
Gross profit (ttm)N/A
EBITDA 34.82B
Net income avi to common (ttm)14.1B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-23.00%

Balance sheet

Total cash (mrq)31.32B
Total cash per share (mrq)33.75
Total debt (mrq)75.1B
Total debt/equity (mrq)75.68%
Current ratio (mrq)0.88
Book value per share (mrq)102.02

Cash flow statement

Operating cash flow (ttm)9.6B
Levered free cash flow (ttm)-15.2B